Karyopharm Therapeutics Inc. (KPTI) Logo

    Karyopharm Therapeutics Inc. (KPTI) symbol, logo with name and high resolution download options.

    Download LogoStock API
    Karyopharm Therapeutics Inc. (KPTI) logo

    Sector

    Healthcare

    Industry

    Biotechnology

    Ticker

    KPTI

    Website

    karyopharm.com

    About Karyopharm Therapeutics Inc. (KPTI)

    Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1). Its lead compound, include XPOVIO in combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma; in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma; and for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It also developing Selinexor for treating hematological and solid tumor malignancies, including multiple myeloma, endometrial cancer, myelofibrosis, and DLBCL; and ELTANEXOR for treating Myelodysplastic Neoplasms, as well as verdinexor, KPT-9274, and IL-12 compounds. In addition, the company has license agreement with Menarini Group to develop and commercialize selinexor for human oncology indications; license agreement with Antengene Therapeutics Limited to develop and commercialize selinexor, eltanexor, and KPT-9274 for the treatment and/or prevention of human oncology indications, as well as verdinexor for the diagnosis, treatment, and/or prevention of human non-oncology indications; and distribution agreement for the commercialization of XPOVIO with FORUS Therapeutics Inc. Further, the company has a collaboration with Bristol Myers Squibb company to evaluate novel cereblon E3 ligase modulator agent mezigdomide in combination with Selinexor in patients with relapsed/refractory multiple myeloma. Karyopharm Therapeutics Inc. was incorporated in 2008 and is headquartered in Newton, Massachusetts.

    ISIN: US48576U2050
    Ticker: 25K0
    Ticker: A40YLC
    Ticker: KPTI

    Get Karyopharm Therapeutics Inc. (KPTI) Logo via API

    Integrate this logo into your application with a single API call

    GET https://api.logostream.dev/stocks/symbol/KPTI?key=YOUR_API_KEY&variant=icon
    View Full Documentation

    Why Use Our Stock Logo API?

    Fast Delivery

    <100ms response time via global CDN

    Enterprise-Ready

    99.99% uptime SLA with GDPR compliance

    Multiple Formats

    SVG, PNG, WebP - scalable to any size

    400k+ Logos

    Stocks, ETFs, Crypto, Banks, and more

    Where to Use Stock Logos

    Trading Platforms

    Real-time stock displays with instant logo loading

    Portfolio Apps

    Visualize holdings with recognizable brand logos

    Financial Dashboards

    Enhance market data with company branding

    News & Research

    Illustrate articles with accurate company logos

    Frequently Asked Questions

    Use our Stock Logo API with the ticker symbol KPTI. Make a GET request to https://api.logostream.dev/stocks/symbol/KPTI?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

    The Karyopharm Therapeutics Inc. (KPTI) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

    With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

    Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/KPTI?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

    Need Stock Logos for Your Application?

    Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.

    View DocumentationRequest API Key